August 12, 2015
RegMed’s mid-day: lean in to the fear, an uptick is happening – get the rebound trade right
August 12, 2015
Lower open expected; RegMed, even traders on Wednesday may be busy watching market signals than the few earnings on the calendar.
August 11, 2015
RegMed’s close: a saw tooth pattern during Q2 financial release period, notice I didn’t say earnings
August 11, 2015
uniQure (QURE) receives $53 M from Bristol-Myers Squibb (BMY) and is UP +$0.19 to $24.13 - BUY
August 4, 2015
RegMed’s close: the lack of indication breaches some technical support levels
August 3, 2015
RegMed’s close: on the first day of trade for August, investors weigh lackluster volume and renewed falloffs
August 2, 2015
RegMed weekend wrap-up: It’s a set-up for next week!
July 30, 2015
RegMed’s mid-day: pick your poison, anticipation or expectation
July 30, 2015
Histogenics (HSGX) new CTO
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.